Tudor Investment Corp ET AL Lowers Stock Position in Enhabit, Inc. $EHAB

Tudor Investment Corp ET AL trimmed its stake in Enhabit, Inc. (NYSE:EHABFree Report) by 24.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 229,191 shares of the company’s stock after selling 74,355 shares during the period. Tudor Investment Corp ET AL owned about 0.45% of Enhabit worth $1,836,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. 8 Knots Management LLC increased its holdings in Enhabit by 9.5% in the 3rd quarter. 8 Knots Management LLC now owns 4,218,846 shares of the company’s stock valued at $33,793,000 after purchasing an additional 365,779 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Enhabit by 96.5% during the second quarter. Arrowstreet Capital Limited Partnership now owns 640,074 shares of the company’s stock worth $6,170,000 after purchasing an additional 314,401 shares in the last quarter. Marshall Wace LLP boosted its position in shares of Enhabit by 59.2% during the third quarter. Marshall Wace LLP now owns 792,981 shares of the company’s stock worth $6,352,000 after buying an additional 294,999 shares during the period. Bank of America Corp DE boosted its position in shares of Enhabit by 73.3% during the third quarter. Bank of America Corp DE now owns 687,934 shares of the company’s stock worth $5,510,000 after buying an additional 290,978 shares during the period. Finally, Vanguard Group Inc. grew its stake in shares of Enhabit by 8.2% in the third quarter. Vanguard Group Inc. now owns 3,393,069 shares of the company’s stock valued at $27,178,000 after buying an additional 256,559 shares in the last quarter.

Enhabit Trading Down 0.0%

NYSE:EHAB opened at $13.66 on Friday. The firm has a market cap of $692.58 million, a PE ratio of -151.72 and a beta of 1.56. The stock has a fifty day moving average price of $12.26 and a 200 day moving average price of $9.97. Enhabit, Inc. has a 12-month low of $6.47 and a 12-month high of $13.69. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.76.

Enhabit (NYSE:EHABGet Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, hitting the consensus estimate of $0.14. The company had revenue of $270.40 million for the quarter, compared to the consensus estimate of $270.56 million. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%. Sell-side analysts anticipate that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Insider Activity at Enhabit

In related news, EVP Julie Diane Jolley sold 2,793 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $13.63, for a total transaction of $38,068.59. Following the sale, the executive vice president directly owned 139,923 shares in the company, valued at approximately $1,907,150.49. This represents a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 3.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on EHAB shares. Truist Financial set a $13.80 target price on Enhabit in a research note on Monday, February 23rd. Leerink Partners lifted their target price on Enhabit from $9.50 to $13.80 and gave the company a “market perform” rating in a research report on Monday, February 23rd. Wolfe Research set a $12.00 price target on shares of Enhabit in a research report on Thursday, January 8th. Jefferies Financial Group lowered shares of Enhabit from a “buy” rating to a “hold” rating and raised their price objective for the company from $12.50 to $13.80 in a research note on Monday, February 23rd. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $13.57.

Get Our Latest Research Report on Enhabit

Enhabit Company Profile

(Free Report)

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.

Featured Stories

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.